About Aalto Pharma

Aalto Pharma is a Swiss pharmaceutical company with the Northern European roots. The company is based in Canton Zug, a heart of Swiss biotech and pharma innovations, and next to a wonderful natural water reservoir, Zugersee.
Aalto in Finnish is a “wave”. Aalto Pharma brings a wave of new products to the pharmaceutical industry.
Our core focus is on treating topical infections caused by bacteria, virus and fungus with supramolecular delivery of API.
We manufacture supramolecular molecules and treatments on one of its kind production equipment and we bring a range of
of solutions with multiple therapeutic indications in both human and animal care.
We run own R&D facility and we collaborate with independent research institutions to rigorously test our innovations and to demonstrate the treatment efficacy. 

Our Products

At Aalto Pharma we invented, manufactured and tested a revolutionary liquid supramolecular API delivery capable of penetrating infected cells and treating a range of topical infections. We focus on treating multiple topical infections with supramolecular API delivery.
Aalto Pharma developed and patented a unique supramolecular delivery platform – an intelligent polymeric carrier that delivers a needed amount of API to the infection area.
Our supramolecular polymer technology ensures safe, effective, fast and sustainable and performance.
We already reordered a tremendous bactericidal performance against the antibiotic resistant bacteria like E. coli, A. baumannii, P. aeruginosa.
Aalto Pharma's supramolecular delivery platform:
- Non-toxic
- Non-comedogenic
- Non-cauterising
- Pharmaceutical and Medical Device status 

Write us a message

.....

Aalto Pharma AG Baar Switzerland info@aaltopharma.com  www.aaltopharma.com
Rathaustrasse 14, CH-6341 Baar, Switzerland